Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CAMP: CAMP4 Therapeutics Corporation Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
CAMP
The Story
CAMP
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+436.5% / yr
Operating margin
-1322.6%
ROIC
-58.3%
Financially safe
Stretched
Debt / equity
0.07×
Interest coverage
0.0×
Current ratio
6.15×
CAMP4 Therapeutics Corporation
CAMP
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
CAMP4 Therapeutics Corporation
CAMP
NASDAQ
·
USD
·
Closed
$3.45
−0.58%
$3.45
−$0.02 (0.58%)
52W Range
33th
pctl
Volume
0.47×
avg
Mkt Cap
73.28M
USD
P/E
-1.5
TTM
Div Yield
–
ann
52W Range
33th
pctl
Volume
0.47×
avg
Market Cap
73.28M
USD
P/E Ratio
-1.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings